Cargando…

Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study

BACKGROUND: Left atrial (LA) size and function are known predictors of new onset atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) patients. Components of LA deformation including reservoir, conduit, and booster function provide additional information on atrial mechanics. Whether or not...

Descripción completa

Detalles Bibliográficos
Autores principales: Raman, Betty, Smillie, Robert W., Mahmod, Masliza, Chan, Kenneth, Ariga, Rina, Nikolaidou, Chrysovalantou, Ormondroyd, Elizabeth, Thomson, Kate, Harper, Andrew R., Tan, Gifford, Lewandowski, Adam J., Rodriguez Bajo, Fernando, Wicks, Eleanor C., Casadei, Barbara, Watkins, Hugh, Neubauer, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504076/
https://www.ncbi.nlm.nih.gov/pubmed/34635131
http://dx.doi.org/10.1186/s12968-021-00793-6
_version_ 1784581257912385536
author Raman, Betty
Smillie, Robert W.
Mahmod, Masliza
Chan, Kenneth
Ariga, Rina
Nikolaidou, Chrysovalantou
Ormondroyd, Elizabeth
Thomson, Kate
Harper, Andrew R.
Tan, Gifford
Lewandowski, Adam J.
Rodriguez Bajo, Fernando
Wicks, Eleanor C.
Casadei, Barbara
Watkins, Hugh
Neubauer, Stefan
author_facet Raman, Betty
Smillie, Robert W.
Mahmod, Masliza
Chan, Kenneth
Ariga, Rina
Nikolaidou, Chrysovalantou
Ormondroyd, Elizabeth
Thomson, Kate
Harper, Andrew R.
Tan, Gifford
Lewandowski, Adam J.
Rodriguez Bajo, Fernando
Wicks, Eleanor C.
Casadei, Barbara
Watkins, Hugh
Neubauer, Stefan
author_sort Raman, Betty
collection PubMed
description BACKGROUND: Left atrial (LA) size and function are known predictors of new onset atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) patients. Components of LA deformation including reservoir, conduit, and booster function provide additional information on atrial mechanics. Whether or not LA deformation can augment our ability to predict the risk of new onset AF in HCM patients beyond standard measurements is unknown. METHODS: We assessed LA size, function, and deformation on cardiovascular magnetic resonance (CMR) in 238 genotyped HCM patients and compared this with twenty age, sex, blood pressure and body mass index matched control subjects. We further evaluated the determinants of new onset AF in HCM patients. RESULTS: Compared to control subjects, HCM patients had higher LA antero-posterior diameter, lower LA ejection fraction and lower LA reservoir (19.9 [17.1, 22.2], 21.6 [19.9, 22.9], P = 0.047) and conduit strain (10.6 ± 4.4, 13.7 ± 3.3, P = 0.002). LA booster strain did not differ between healthy controls and HCM patients, but HCM patients who developed new onset AF (n = 33) had lower booster strain (7.6 ± 3.3, 9.5 ± 3.0, P = 0.001) than those that did not (n = 205). In separate multivariate models, age, LA ejection fraction, and LA booster and reservoir strain were each independent determinants of AF. Age ≥ 55 years was the strongest determinant (HR 6.62, 95% CI 2.79–15.70), followed by LA booster strain ≤ 8% (HR 3.69, 95% CI 1.81–7.52) and LA reservoir strain ≤ 18% (HR 2.56, 95% CI 1.24–5.27). Conventional markers of HCM phenotypic severity, age and sudden death risk factors were associated with LA strain components. CONCLUSIONS: LA strain components are impaired in HCM and, together with age, independently predicted the risk of new onset AF. Increasing age and phenotypic severity were associated with LA strain abnormalities. Our findings suggest that the routine assessment of LA strain components and consideration of age could augment LA size in predicting risk of AF, and potentially guide prophylactic anticoagulation use in HCM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-021-00793-6.
format Online
Article
Text
id pubmed-8504076
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85040762021-10-25 Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study Raman, Betty Smillie, Robert W. Mahmod, Masliza Chan, Kenneth Ariga, Rina Nikolaidou, Chrysovalantou Ormondroyd, Elizabeth Thomson, Kate Harper, Andrew R. Tan, Gifford Lewandowski, Adam J. Rodriguez Bajo, Fernando Wicks, Eleanor C. Casadei, Barbara Watkins, Hugh Neubauer, Stefan J Cardiovasc Magn Reson Research BACKGROUND: Left atrial (LA) size and function are known predictors of new onset atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) patients. Components of LA deformation including reservoir, conduit, and booster function provide additional information on atrial mechanics. Whether or not LA deformation can augment our ability to predict the risk of new onset AF in HCM patients beyond standard measurements is unknown. METHODS: We assessed LA size, function, and deformation on cardiovascular magnetic resonance (CMR) in 238 genotyped HCM patients and compared this with twenty age, sex, blood pressure and body mass index matched control subjects. We further evaluated the determinants of new onset AF in HCM patients. RESULTS: Compared to control subjects, HCM patients had higher LA antero-posterior diameter, lower LA ejection fraction and lower LA reservoir (19.9 [17.1, 22.2], 21.6 [19.9, 22.9], P = 0.047) and conduit strain (10.6 ± 4.4, 13.7 ± 3.3, P = 0.002). LA booster strain did not differ between healthy controls and HCM patients, but HCM patients who developed new onset AF (n = 33) had lower booster strain (7.6 ± 3.3, 9.5 ± 3.0, P = 0.001) than those that did not (n = 205). In separate multivariate models, age, LA ejection fraction, and LA booster and reservoir strain were each independent determinants of AF. Age ≥ 55 years was the strongest determinant (HR 6.62, 95% CI 2.79–15.70), followed by LA booster strain ≤ 8% (HR 3.69, 95% CI 1.81–7.52) and LA reservoir strain ≤ 18% (HR 2.56, 95% CI 1.24–5.27). Conventional markers of HCM phenotypic severity, age and sudden death risk factors were associated with LA strain components. CONCLUSIONS: LA strain components are impaired in HCM and, together with age, independently predicted the risk of new onset AF. Increasing age and phenotypic severity were associated with LA strain abnormalities. Our findings suggest that the routine assessment of LA strain components and consideration of age could augment LA size in predicting risk of AF, and potentially guide prophylactic anticoagulation use in HCM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-021-00793-6. BioMed Central 2021-10-11 /pmc/articles/PMC8504076/ /pubmed/34635131 http://dx.doi.org/10.1186/s12968-021-00793-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Raman, Betty
Smillie, Robert W.
Mahmod, Masliza
Chan, Kenneth
Ariga, Rina
Nikolaidou, Chrysovalantou
Ormondroyd, Elizabeth
Thomson, Kate
Harper, Andrew R.
Tan, Gifford
Lewandowski, Adam J.
Rodriguez Bajo, Fernando
Wicks, Eleanor C.
Casadei, Barbara
Watkins, Hugh
Neubauer, Stefan
Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
title Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
title_full Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
title_fullStr Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
title_full_unstemmed Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
title_short Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
title_sort incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504076/
https://www.ncbi.nlm.nih.gov/pubmed/34635131
http://dx.doi.org/10.1186/s12968-021-00793-6
work_keys_str_mv AT ramanbetty incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT smillierobertw incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT mahmodmasliza incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT chankenneth incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT arigarina incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT nikolaidouchrysovalantou incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT ormondroydelizabeth incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT thomsonkate incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT harperandrewr incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT tangifford incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT lewandowskiadamj incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT rodriguezbajofernando incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT wickseleanorc incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT casadeibarbara incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT watkinshugh incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy
AT neubauerstefan incrementalvalueofleftatrialboosterandreservoirstraininpredictingatrialfibrillationinpatientswithhypertrophiccardiomyopathyacardiovascularmagneticresonancestudy